NUDT15 (Q9NV35) variants and mutations
NUDT15 (also known as Q9NV35) is a human protein-coding gene encoding a nucleotide triphosphate diphosphatase protein. It hydrolyzes active thioguanine nucleotide metabolites and limits their incorporation into DNA during thiopurine treatment. Reduced-function variants can cause profound myelosuppression at standard doses, making NUDT15 genotype clinically important for thiopurine dosing. This analysis covers 488 NUDT15 variants and mutations. Of these, 97% have computational variant effect predictions. Disease context includes Decreased total leukocyte count, alopecia, and preeclampsia. Example NUDT15 variants include M1I, T2A, and T2K.
Variant analysis overview
- Gene: NUDT15
- Protein: Q9NV35
- UniProt accession: Q9NV35
- Organism: Homo sapiens
- Variants analyzed: 488
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 227 unspecified-consequence records; 34 frameshift variants; 121 missense variants; 81 synonymous variants; 11 in-frame deletions; 7 stop-gained variants; 2 in-frame insertions; 2 splice-region variants; 2 stop lost; 1 substitution
- Prediction scores: 472 variants have prediction scores (97% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Decreased total leukocyte count, alopecia, preeclampsia, acute lymphoblastic leukemia, cancer, disease of peritoneum, lagophthalmos, alcohol drinking, nonimmune chronic idiopathic neutropenia of adults, amegakaryocytic thrombocytopenia, congenital, 2, neoplasm, acute erythroid leukemia.
Protein structure and variant hotspots
- Protein features: 1 domains; 5 binding sites.
- Structural context: 380 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NUDT15 variants
Examples include M1I, T2A, T2K, T2M, T2P, T2R, T2S, T2T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs941255227, []
- T2A (p.Thr2Ala), ExAC rs780144127, TOPMed rs780144127, gnomAD rs780144127, REVEL 0.01, MetaLR 0.03
- T2K (p.Thr2Lys), ExAC rs749250312, TOPMed rs749250312, gnomAD rs749250312, REVEL 0.07, MetaLR 0.05
- T2M (p.Thr2Met), ExAC rs749250312, TOPMed rs749250312, gnomAD rs749250312, REVEL 0.08, MetaLR 0.04
- T2P (p.Thr2Pro), ExAC rs780144127, TOPMed rs780144127, gnomAD rs780144127, MetaLR 0.04, MetaSVM -1.03
- T2R (p.Thr2Arg), ExAC rs749250312, TOPMed rs749250312, gnomAD rs749250312, REVEL 0.05, MetaLR 0.05
- T2S (p.Thr2Ser), gnomAD 13-48037750-A-T, REVEL 0.01, MetaLR 0.03
- T2T (p.Thr2Thr), rs200646172, gnomAD 13-48037752-G-A, CADD 2.22
- A3G (p.Ala3Gly), ExAC rs768620317, TOPMed rs768620317, gnomAD rs768620317, REVEL 0.02, MetaLR 0.07
- A3S (p.Ala3Ser), gnomAD 13-48037753-G-T, REVEL 0.11, MetaLR 0.07
- A3T (p.Ala3Thr), gnomAD 13-48037753-G-A, REVEL 0.11, MetaLR 0.06
- A3D (p.Ala3Asp), gnomAD 13-48037754-C-A, REVEL 0.02, MetaLR 0.07
- A3A (p.Ala3Ala), gnomAD 13-48037755-C-A, CADD 8.00
- S4C (p.Ser4Cys), Ensembl rs778438727, MetaLR 0.06, MetaSVM -0.96
- S4G (p.Ser4Gly), Ensembl rs778438727, REVEL 0.04, MetaLR 0.04
- S4N (p.Ser4Asn), gnomAD rs1484761743, REVEL 0.01, MetaLR 0.03
- S4R (p.Ser4Arg), TOPMed rs1184430330, gnomAD rs1184430330, REVEL 0.01, MetaLR 0.05
- S4T (p.Ser4Thr), gnomAD rs1484761743, REVEL 0.03, MetaLR 0.04
- S4A (p.Ser4Ala), rs757433141, gnomAD 13-48037750-ACGGC, CADD 22.50
- S4S (p.Ser4Ser), rs1184430330, gnomAD 13-48037758-C-T, CADD 6.02
- A5G (p.Ala5Gly), ExAC rs761635179, TOPMed rs761635179, gnomAD rs761635179, REVEL 0.01, MetaLR 0.04
- A5P (p.Ala5Pro), gnomAD rs1950542791, MetaLR 0.04, MetaSVM -1.04
- A5T (p.Ala5Thr), gnomAD rs1950542791, REVEL 0.02, MetaLR 0.06
- A5V (p.Ala5Val), ExAC rs761635179, TOPMed rs761635179, gnomAD rs761635179, REVEL 0.01, MetaLR 0.06
- A5S (p.Ala5Ser), gnomAD 13-48037759-G-T, REVEL 0.02, MetaLR 0.06
- A5E (p.Ala5Glu), gnomAD 13-48037760-C-A, REVEL 0.01, MetaLR 0.06
- A5A (p.Ala5Ala), gnomAD 13-48037761-A-C, CADD 6.70
- Q6* (p.Gln6Ter), ExAC rs776779121, gnomAD rs776779121, CADD 35.00
- Q6E (p.Gln6Glu), ExAC rs776779121, gnomAD rs776779121, REVEL 0.13, MetaLR 0.02
- Q6S (p.Gln6Ser), rs1566105829, gnomAD 13-48037760-CA-C, CADD 15.20
- Q6K (p.Gln6Lys), gnomAD 13-48037762-C-A, REVEL 0.11, MetaLR 0.03
- Q6R (p.Gln6Arg), gnomAD 13-48037763-A-G, REVEL 0.04, MetaLR 0.03
- Q6Q (p.Gln6Gln), rs1950542954, gnomAD 13-48037764-G-A, CADD 5.16
- Q6H (p.Gln6His), gnomAD 13-48037764-G-T, REVEL 0.03, MetaLR 0.03
- P7L (p.Pro7Leu), Ensembl rs2137793892, REVEL 0.06, MetaLR 0.05
- P7S (p.Pro7Ser), TOPMed rs1240232167, gnomAD rs1240232167, REVEL 0.09, MetaLR 0.07
- P7A (p.Pro7Ala), gnomAD 13-48037764-GCC-G, CADD 14.00
- P7R (p.Pro7Arg), gnomAD 13-48037766-C-G, REVEL 0.04, MetaLR 0.05
- P7Q (p.Pro7Gln), gnomAD 13-48037766-C-A, REVEL 0.03, MetaLR 0.04
- P7P (p.Pro7Pro), gnomAD 13-48037767-G-C, CADD 2.54
- R8G (p.Arg8Gly), gnomAD rs1950542990, REVEL 0.03, MetaLR 0.04
- R8L (p.Arg8Leu), Ensembl rs1950543011, MetaLR 0.03, MetaSVM -1.02
- R8S (p.Arg8Ser), gnomAD 13-48037767-G-GT, CADD 17.60
- R8C (p.Arg8Cys), gnomAD 13-48037768-C-T, REVEL 0.04, MetaLR 0.04
- R8H (p.Arg8His), gnomAD 13-48037769-G-A, REVEL 0.03, MetaLR 0.02
- R8P (p.Arg8Pro), gnomAD 13-48037769-G-C, REVEL 0.03, MetaLR 0.03
- R8R (p.Arg8Arg), gnomAD 13-48037770-C-A, CADD 4.91
- G9E (p.Gly9Glu), TOPMed rs1379693700, gnomAD rs1379693700, REVEL 0.04, MetaLR 0.03
- G9R (p.Gly9Arg), ExAC rs759619545, TOPMed rs759619545, gnomAD rs759619545, REVEL 0.03, MetaLR 0.03, Uncertain significance
- G9V (p.Gly9Val), TOPMed rs1379693700, gnomAD rs1379693700, REVEL 0.03, MetaLR 0.03
- G9W (p.Gly9Trp), ExAC rs759619545, TOPMed rs759619545, gnomAD rs759619545, REVEL 0.07, MetaLR 0.03, Uncertain significance, not provided
- G9A (p.Gly9Ala), rs1312777893, gnomAD 13-48037770-CGGGC, CADD 19.50
- G9G (p.Gly9Gly), rs765370919, gnomAD 13-48037773-G-C, CADD 3.75
- R10G (p.Arg10Gly), ExAC rs775629796, TOPMed rs775629796, gnomAD rs775629796
- R10Q (p.Arg10Gln), Ensembl rs1950543153, MetaLR 0.02, MetaSVM -0.96
- R10W (p.Arg10Trp), ExAC rs775629796, TOPMed rs775629796, gnomAD rs775629796, REVEL 0.02, MetaLR 0.02
- R10L (p.Arg10Leu), gnomAD 13-48037775-G-T, REVEL 0.01, MetaLR 0.02
- R10R (p.Arg10Arg), rs763419258, gnomAD 13-48037776-G-A, CADD 5.41
- R11G (p.Arg11Gly), Ensembl rs2137793966, REVEL 0.29, MetaLR 0.13
- R11P (p.Arg11Pro), ExAC rs764632714, TOPMed rs764632714, gnomAD rs764632714, REVEL 0.37, MetaLR 0.10
- R11Q (p.Arg11Gln), ExAC rs764632714, TOPMed rs764632714, gnomAD rs764632714, REVEL 0.29, MetaLR 0.04
- R11W (p.Arg11Trp), gnomAD 13-48037777-C-T, REVEL 0.27, MetaLR 0.13
- R11R (p.Arg11Arg), gnomAD 13-48037777-C-A, CADD 9.87
- R11L (p.Arg11Leu), gnomAD 13-48037778-G-T, REVEL 0.36, MetaLR 0.12
- P12L (p.Pro12Leu), 1000Genomes rs528005656, ExAC rs528005656, TOPMed rs528005656, gnomAD rs528005656, REVEL 0.27, MetaLR 0.22
- P12Q (p.Pro12Gln), 1000Genomes rs528005656, ExAC rs528005656, TOPMed rs528005656, gnomAD rs528005656, MetaLR 0.37, MetaSVM -0.00
- P12R (p.Pro12Arg), 1000Genomes rs528005656, ExAC rs528005656, TOPMed rs528005656, gnomAD rs528005656, REVEL 0.34, MetaLR 0.37
- P12S (p.Pro12Ser), gnomAD 13-48037780-C-T, REVEL 0.34, MetaLR 0.40
- P12T (p.Pro12Thr), gnomAD 13-48037780-C-A, REVEL 0.36, MetaLR 0.36
- P12P (p.Pro12Pro), gnomAD 13-48037782-A-T, CADD 0.49
- G13A (p.Gly13Ala), 1000Genomes rs567318719, ExAC rs567318719, TOPMed rs567318719, gnomAD rs567318719, REVEL 0.25, MetaLR 0.12
- G13E (p.Gly13Glu), 1000Genomes rs567318719, ExAC rs567318719, TOPMed rs567318719, gnomAD rs567318719, REVEL 0.27, MetaLR 0.15
- G13R (p.Gly13Arg), ExAC rs767290343, TOPMed rs767290343, gnomAD rs767290343, REVEL 0.34, MetaLR 0.08
- G13* (p.Gly13Ter), gnomAD 13-48037783-G-T, CADD 40.00
- G13V (p.Gly13Val), gnomAD 13-48037784-G-T, REVEL 0.33, MetaLR 0.12
- G13G (p.Gly13Gly), rs1304643193, gnomAD 13-48037785-A-G, CADD 7.94
- V14D (p.Val14Asp), TOPMed rs1428135695, REVEL 0.44, MetaLR 0.39
- V14G (p.Val14Gly), TOPMed rs1428135695, MetaLR 0.33, MetaSVM -0.21
- V14I (p.Val14Ile), TOPMed rs994248042, gnomAD rs994248042, REVEL 0.15, MetaLR 0.09
- V14F (p.Val14Phe), gnomAD 13-48037786-G-T, REVEL 0.31, MetaLR 0.32
- V14V (p.Val14Val), rs1233679343, gnomAD 13-48037788-C-A, CADD 6.86
- G15* (p.Gly15Ter), Ensembl rs866472485
- G15A (p.Gly15Ala), gnomAD rs1345971588, REVEL 0.19, MetaLR 0.04
- G15E (p.Gly15Glu), NCI-TCGA TCGA novel, REVEL 0.33, MetaLR 0.15, Variant assessed as somatic; high impact.
- G15R (p.Gly15Arg), NCI-TCGA TCGA novel, MetaLR 0.08, MetaSVM -1.08, Variant assessed as somatic; moderate impact.
- G15G (p.Gly15Gly), gnomAD 13-48037791-A-T, CADD 2.40
- V16A (p.Val16Ala), ExAC rs779488127, TOPMed rs779488127, gnomAD rs779488127, REVEL 0.35, MetaLR 0.09
- V16D (p.Val16Asp), ExAC rs779488127, TOPMed rs779488127, gnomAD rs779488127, REVEL 0.44, MetaLR 0.27
- V16I (p.Val16Ile), TOPMed rs1023262224, gnomAD rs1023262224, REVEL 0.10, MetaLR 0.07
- V16R (p.Val16Arg), rs1279959716, gnomAD 13-48037789-GGA-G, CADD 26.30
- V16L (p.Val16Leu), gnomAD 13-48037792-G-C, REVEL 0.17, MetaLR 0.10
- V16V (p.Val16Val), rs754908546, gnomAD 13-48037794-C-A, CADD 0.37
- G17R (p.Gly17Arg), Ensembl rs1950543785, REVEL 0.58, MetaLR 0.11
- p.Gly17 Val18del, rs746071566, gnomAD 13-48037782-AGGAG, CADD 19.60
- G17* (p.Gly17Ter), gnomAD 13-48037795-G-T, CADD 40.00
- G17E (p.Gly17Glu), gnomAD 13-48037796-G-A, REVEL 0.37, MetaLR 0.12
- G17V (p.Gly17Val), gnomAD 13-48037796-G-T, REVEL 0.29, MetaLR 0.09
- G17G (p.Gly17Gly), gnomAD 13-48037797-A-C, CADD 5.62
- V18A (p.Val18Ala), TOPMed rs1434156465, gnomAD rs1434156465, REVEL 0.25, MetaLR 0.07
- V18I (p.Val18Ile), rs186364861, ClinGen CA358313, ClinVar RCV000210850, ClinVar RCV003937795, REVEL 0.27, MetaLR 0.06, Likely benign; drug response, Thiopurines, poor metabolism of, 2; NUDT15-related disorder
- p.Val18 Val19insArgVal, gnomAD 13-48037795-G-GGA, CADD 19.80
- V18V (p.Val18Val), rs375436751, gnomAD 13-48037800-C-G, CADD 0.83
- V19M (p.Val19Met), Ensembl rs1950543978, REVEL 0.14, MetaLR 0.07
- p.Val19 Val20del, rs768550630, gnomAD 13-48037797-AGTCG, CADD 20.10
- V19L (p.Val19Leu), gnomAD 13-48037801-G-T, REVEL 0.11, MetaLR 0.02
- V19A (p.Val19Ala), gnomAD 13-48037802-T-C, REVEL 0.16, MetaLR 0.05
- V19G (p.Val19Gly), gnomAD 13-48037802-T-G, REVEL 0.30, MetaLR 0.11
- V19V (p.Val19Val), gnomAD 13-48037803-G-C, CADD 8.86
- V20L (p.Val20Leu), TOPMed rs1950544019, REVEL 0.08, MetaLR 0.03
- V20A (p.Val20Ala), gnomAD 13-48037805-T-C, REVEL 0.25, MetaLR 0.10
- V20V (p.Val20Val), rs771790276, gnomAD 13-48037806-G-T, CADD 6.37
- T21A (p.Thr21Ala), Ensembl rs1950544066
- T21I (p.Thr21Ile), NCI-TCGA Cosmic COSV9932, MetaLR 0.07, MetaSVM -1.13, Variant assessed as somatic; moderate impact.
- T21N (p.Thr21Asn), gnomAD 13-48037808-C-A, REVEL 0.24, MetaLR 0.12
- T21T (p.Thr21Thr), gnomAD 13-48037809-C-A, CADD 2.93
- S22R (p.Ser22Arg), Ensembl rs1950544125, REVEL 0.28, MetaLR 0.03
- S22T (p.Ser22Thr), Ensembl rs990805972, MetaLR 0.05, MetaSVM -1.12
- S22E (p.Ser22Glu), gnomAD 13-48037795-G-GGA, CADD 27.70
- S22N (p.Ser22Asn), gnomAD 13-48037811-G-A, REVEL 0.18, MetaLR 0.02
- S22S (p.Ser22Ser), rs1950544125, gnomAD 13-48037812-C-T, CADD 10.20
- C23G (p.Cys23Gly), NCI-TCGA Cosmic COSV9932, REVEL 0.08, MetaLR 0.00, Variant assessed as somatic; moderate impact.
- C23Y (p.Cys23Tyr), TOPMed rs1950544157, REVEL 0.05, MetaLR 0.01
- C23S (p.Cys23Ser), gnomAD 13-48037813-T-A, REVEL 0.07, MetaLR 0.00
- C23* (p.Cys23Ter), gnomAD 13-48037815-C-A, CADD 35.00
- K24N (p.Lys24Asn), 1000Genomes rs549709884, ExAC rs549709884, TOPMed rs549709884, gnomAD rs549709884, REVEL 0.06, MetaLR 0.02
- K24R (p.Lys24Arg), TOPMed rs1003070511, REVEL 0.01, MetaLR 0.01
- p.Lys24 His25insLeuValThrSerCysL, gnomAD 13-48037801-G-GTG, CADD 19.10
- K24K (p.Lys24Lys), rs549709884, gnomAD 13-48037818-G-A, CADD 5.42
- H25P (p.His25Pro), rs2541745312, ClinGen CA388149921, ClinVar RCV004307816, Uncertain significance, not specified
- H25Y (p.His25Tyr), gnomAD rs1461444516, MetaLR 0.06, MetaSVM -1.15
- H25N (p.His25Asn), gnomAD 13-48037819-C-A, REVEL 0.15, MetaLR 0.03
- P26A (p.Pro26Ala), ExAC rs561923692, TOPMed rs561923692, gnomAD rs561923692, REVEL 0.20, MetaLR 0.06
- P26L (p.Pro26Leu), ExAC rs775476759, gnomAD rs775476759, REVEL 0.27, MetaLR 0.13
- P26Q (p.Pro26Gln), rs775476759, ClinGen CA388149928, ClinVar RCV004270338, REVEL 0.29, MetaLR 0.10, Uncertain significance, not specified
- P26S (p.Pro26Ser), gnomAD 13-48037822-C-T, REVEL 0.18, MetaLR 0.07
- P26P (p.Pro26Pro), rs1441438453, gnomAD 13-48037824-G-A, CADD 3.46
- R27L (p.Arg27Leu), ExAC rs763051893, gnomAD rs763051893, REVEL 0.07, MetaLR 0.02
- R27S (p.Arg27Ser), gnomAD 13-48037825-C-A, REVEL 0.04, MetaLR 0.03
- R27H (p.Arg27His), gnomAD 13-48037826-G-A, REVEL 0.07, MetaLR 0.02
- R27R (p.Arg27Arg), rs764533431, gnomAD 13-48037827-T-C, CADD 2.17
- C28W (p.Cys28Trp), ExAC rs774866501, gnomAD rs774866501, MetaLR 0.10, MetaSVM -0.97
- C28G (p.Cys28Gly), rs777311140, gnomAD 13-48037825-C-CGC, CADD 22.90
- C28R (p.Cys28Arg), gnomAD 13-48037828-T-C, REVEL 0.25, MetaLR 0.02
- C28* (p.Cys28Ter), gnomAD 13-48037830-C-A, CADD 35.00
- C28C (p.Cys28Cys), gnomAD 13-48037830-C-T, CADD 7.38
- V29I (p.Val29Ile), ExAC rs762270086, TOPMed rs762270086, gnomAD rs762270086, REVEL 0.11, MetaLR 0.03, Uncertain significance, not specified
- V29L (p.Val29Leu), ExAC rs762270086, TOPMed rs762270086, gnomAD rs762270086, REVEL 0.24, MetaLR 0.09, Uncertain significance
- V29F (p.Val29Phe), gnomAD 13-48037831-G-T, REVEL 0.34, MetaLR 0.11
- L30F (p.Leu30Phe), TOPMed rs1202487323, gnomAD rs1202487323, MetaLR 0.26, MetaSVM -0.51
- L30V (p.Leu30Val), TOPMed rs1202487323, gnomAD rs1202487323, REVEL 0.24, MetaLR 0.22
- L30I (p.Leu30Ile), gnomAD 13-48037834-C-A, REVEL 0.25, MetaLR 0.25
- L30L (p.Leu30Leu), gnomAD 13-48037836-C-T, CADD 6.01
- L31V (p.Leu31Val), TOPMed rs752857256, REVEL 0.13, MetaLR 0.08
- L31L (p.Leu31Leu), gnomAD 13-48037837-C-T, CADD 8.97
- L31Q (p.Leu31Gln), gnomAD 13-48037838-T-A, REVEL 0.53, MetaLR 0.27
- L31P (p.Leu31Pro), gnomAD 13-48037838-T-C, REVEL 0.53, MetaLR 0.33
- L31R (p.Leu31Arg), gnomAD 13-48037838-T-G, REVEL 0.51, MetaLR 0.25
- G32R (p.Gly32Arg), gnomAD 13-48037840-G-C, REVEL 0.51, MetaLR 0.13
- G32E (p.Gly32Glu), gnomAD 13-48037841-G-A, REVEL 0.55, MetaLR 0.10
- G32G (p.Gly32Gly), gnomAD 13-48037842-G-A, CADD 6.45
- K33E (p.Lys33Glu), rs768057637, ExAC rs768057637, TOPMed rs768057637, gnomAD rs768057637, REVEL 0.34, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- K33N (p.Lys33Asn), 1000Genomes rs150241065, ESP rs150241065, ExAC rs150241065, TOPMed rs150241065, REVEL 0.21, MetaLR 0.07
- K33R (p.Lys33Arg), gnomAD 13-48037838-TG-T, CADD 23.60
- K33T (p.Lys33Thr), gnomAD 13-48037844-A-C, REVEL 0.21, MetaLR 0.08
- K33K (p.Lys33Lys), rs150241065, gnomAD 13-48037845-G-A, CADD 8.91
- R34K (p.Arg34Lys), ExAC rs766023281, TOPMed rs766023281, gnomAD rs766023281, REVEL 0.26, MetaLR 0.11
- R34S (p.Arg34Ser), NCI-TCGA Cosmic COSV5164, REVEL 0.50, MetaLR 0.22, Variant assessed as somatic; moderate impact.
- R34T (p.Arg34Thr), ExAC rs766023281, TOPMed rs766023281, gnomAD rs766023281, REVEL 0.65, MetaLR 0.21
- R34G (p.Arg34Gly), gnomAD 13-48037846-A-G, REVEL 0.37, MetaLR 0.20
- K35E (p.Lys35Glu), NCI-TCGA TCGA novel, MetaLR 0.06, MetaSVM -1.13, Variant assessed as somatic; moderate impact.
- K35K (p.Lys35Lys), gnomAD 13-48037851-A-G, CADD 9.30
- G36C (p.Gly36Cys), ExAC rs753319151, TOPMed rs753319151, gnomAD rs753319151, REVEL 0.18, MetaLR 0.04
- G36R (p.Gly36Arg), ExAC rs753319151, TOPMed rs753319151, gnomAD rs753319151, REVEL 0.17, MetaLR 0.04
- G36V (p.Gly36Val), gnomAD rs1452220226, REVEL 0.19, MetaLR 0.05
- G36D (p.Gly36Asp), gnomAD 13-48037853-G-A, REVEL 0.17, MetaLR 0.02
- S37* (p.Ser37Ter), ExAC rs778722701, TOPMed rs778722701, gnomAD rs778722701, CADD 36.00
- S37L (p.Ser37Leu), ExAC rs778722701, TOPMed rs778722701, gnomAD rs778722701, REVEL 0.07, MetaLR 0.03
- S37W (p.Ser37Trp), ExAC rs778722701, TOPMed rs778722701, gnomAD rs778722701, REVEL 0.05, MetaLR 0.07
- S37S (p.Ser37Ser), rs758319847, gnomAD 13-48037857-G-C, CADD 2.37
- V38A (p.Val38Ala), TOPMed rs1427452470, gnomAD rs1427452470, REVEL 0.08, MetaLR 0.02
Public NUDT15 analysis runs
- NUDT15 analysis run — NUDT15 (488 variants) — completed 2026-08-18